-
Sector Analysis
Italy Wind Power Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
Italy Wind Power Market Report Overview The wind power installed capacity was 11.87 GW in 2022 and will grow at a CAGR of more than 8% during 2022-2035. The following are some of the key highlights of the Italy wind power market: In 2022, solar PV power led the renewable capacity mix in Italy. In Italy, onshore wind power technology accounted for the highest share of the total wind power generation. Factors such as the need to achieve energy stability...
-
Sector Analysis
Italy Hydropower Market Analysis by Size, Installed Capacity, Power Generation, Regulations, Key Players and Forecast to 2035
Italy Hydropower Market Report Overview The cumulative capacity for hydropower in Italy was 22.9 GW in 2022. The Italy hydropower market is anticipated to increase at a CAGR of less than 1% during the projected period. The following are some of the key highlights of the Italy hydropower market: Large hydro and pumped storage is expected to have a significant share in the cumulative capacity mix by the year 2035. In 2022, Italian hydropower market recorded a significant number of...
-
Product Insights
Acea – Rome Waste to Energy Plant – Latium
Equip yourself with the essential tools needed to make informed and profitable decisions with our Acea - Rome Waste to Energy Plant - Latium report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Acea Distri – Rome Electricity Distribution Network Expansion – Latium
Equip yourself with the essential tools needed to make informed and profitable decisions with our Acea Distri - Rome Electricity Distribution Network Expansion - Latium report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Acea – Ottana Solar Power Plant 85 MW – Sardinia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Acea - Ottana Solar Power Plant 85 MW - Sardinia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
Acea SpA – Company Profile
Acea SpA (Acea), a subsidiary of Roma Capitale, is a multi-utility company that provides energy services. The company generates and supplies electricity and supplies natural gas. It produces electricity from hydro, thermal, and solar sources in Lazio, Umbria and Abruzzo. Acea provides integrated water services such as aqueducts, sewerage and purification in Rome and Frosinone and in the respective provinces, as well as in other parts of Tuscany, Lazio, Umbria and Campania. It distributes electricity and manages public and artistic...
Add to Basket -
Product Insights
Fergas Solar PV Park
Fergas solar PV Park is a 20MW solar PV power project located in Basilicata, Italy. The project is currently in the permitting stage. The project is owned by Acea SpA. Fergas solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital expenditure etc. Details on project specific contacts along with relevant news, deals and contracts...
-
Product Insights
Coccidioidomycosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Coccidioidomycosis, also called Valley fever, is an infection caused by the fungus Coccidioides. Symptoms include fever, cough, chest pain, chills, headache, fatigue, and joint aches. Risk factors include the weakened immune system, age, pregnancy, race, and environmental exposure. Treatment includes antifungal medications. The Coccidioidomycosis drugs in development market research report provide comprehensive information on the therapeutics under development for Coccidioidomycosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type....
-
Product Insights
Onychomycosis (Tinea Unguium) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Onychomycosis (Tinea Unguium) pipeline research report provides comprehensive information on the therapeutics under development for Onychomycosis (Tinea Unguium), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features...
-
Sector Analysis
Non-Small Cell Lung Cancer – Global Drug Forecast and Market Analysis to 2029
Non-small cell lung cancer (NSCLC) is currently the most common cancer in the world and is the leading cause of cancer mortality in men and women. Of total lung cancer incident cases, approximately 85% are the NSCLC subtype. NSCLC patients are usually diagnosed in the later stages of the disease, resulting in a poor prognosis. Since the last global market forecast (2015–2025), there have been significant changes in the treatment of patients with advanced disease, particularly in the metastatic setting....